Centene Projects Decline in Medicaid Membership Amid Regulatory Changes

Centene announced a projected decline in membership within its Medicaid plans aimed at lower-income individuals, leading to a stock decrease of almost 6% in early trading. The insurer now anticipates an 8%-9% reduction in Medicaid membership throughout the year, an increase from the previously expected 6% decrease.

The projected decline in Medicaid enrollment is attributed to regulatory changes enforcing work requirements for low-income individuals availing of these government-funded plans. These requirements are expected to be fully implemented by January 1, 2027. CEO Sarah London emphasized the significance of this issue during a post-earnings conference call, mentioning efforts to restore profitability to the company's Medicaid segment in the coming years.

Centene has witnessed an increase in membership involving patients with higher healthcare needs, particularly from populations integrated into Medicaid following state expansions under the Affordable Care Act. This trend correlates with heightened attrition observed in the recent quarter. As healthcare usage patterns normalize post-pandemic and states enact stricter eligibility standards, Centene's membership has seen an influx of individuals with elevated health service usage. Chief Financial Officer Drew Asher noted that the losses are primarily driven by the Medicaid expansion group, comprising higher-income individuals.

Julie Utterback, an analyst with Morningstar, commented that while this situation may lead to stock volatility through 2027, the underlying risk is not unfamiliar to the market. Health insurers like Centene have faced challenges due to a disconnect between payment rates and the demand for healthcare services over recent years.

The company's medical loss ratio for the second quarter, which represents the portion of premiums invested in medical care, was 89.6%. This figure is lower than the 93% from last year and below the 91.30% projected by analysts, according to data from LSEG. Centene attributed the reduced costs to better pricing of Affordable Care Act plans and enhancements from risk-adjustment payments, compensating insurers covering a relatively higher number of high-risk members.

The ending of additional COVID-19 pandemic-related subsidies has led to reduced enrollment in the Affordable Care Act plans as individuals find it challenging to afford their health plans. In spite of these challenges, Centene revised upwards its adjusted profit forecast for 2026 to over $4.80 per share from above $3.40, exceeding the analyst expectation of $3.52.

Centene also reported an adjusted profit per share of $2.51 for the recent quarter, outpacing the estimated $1.09.